BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2411437)

  • 41. Active rosette-forming lymphocytes in chronic hepatitis.
    Stanciu L; Urcan S; Părău N; Radu D; Popescu S
    Med Interne; 1982; 20(4):277-82. PubMed ID: 6985551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The immunotherapy of type-1 diabetes mellitus--experiences, results and prospects].
    Manov A
    Vutr Boles; 1990; 29(4):22-7. PubMed ID: 1704164
    [No Abstract]   [Full Text] [Related]  

  • 43. Immunotherapy of chronic active viral hepatitis B with propionibacterium granulosum.
    Gil J; Ziemka J; Brzosko WJ; Dabrowski M; Dabrowska-Bernstein B; Szmigielski S; Ko HL; Jeljaszewicz J; Pulverer G
    Hepatogastroenterology; 1984 Jun; 31(3):109-18. PubMed ID: 6205967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of chronic hepatitis type virus B.
    Schalm SW
    Hepatogastroenterology; 1984 Feb; 31(1):12-6. PubMed ID: 6199273
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Diagnosis of treated and untreated chronic-aggressive hepatitis].
    Knoblauch M; Ammann R; Clavadetscher P; Grob P; Schmid M
    Schweiz Med Wochenschr; 1976 Feb; 106(9):315-6. PubMed ID: 1257731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. D-penicillamine therapy in patients with HBsAg-negative chronic active hepatitis and major prednisolone-induced adverse effects.
    McClements BM; Callender ME
    J Hepatol; 1990 Nov; 11(3):322-5. PubMed ID: 2290022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Chronic hepatitis].
    Gaye-Bareyt E; Delas N
    Soins; 1990 Mar; (534):14-6. PubMed ID: 2353226
    [No Abstract]   [Full Text] [Related]  

  • 48. [Therapy of chronic progessive hepatitis].
    Fossati C
    Clin Ter; 1980 Aug; 94(4):481-6. PubMed ID: 7006887
    [No Abstract]   [Full Text] [Related]  

  • 49. Prognosis of corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis in postmenopausal women: a retrospective analysis.
    Wang KK; Czaja AJ
    Gastroenterology; 1989 Nov; 97(5):1288-93. PubMed ID: 2792661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The detrimental effects of adrenocorticosteroid therapy in HBsAg-positive chronic active hepatitis: fact or artifact?
    Conn H; Maddrey WC; Soloway RD
    Hepatology; 1982; 2(6):885-7. PubMed ID: 7141399
    [No Abstract]   [Full Text] [Related]  

  • 51. [Therapy of amyloidoses].
    Missmahl HP; Willemsen M
    Dtsch Med Wochenschr; 1977 Nov; 102(44):1593-5. PubMed ID: 923434
    [No Abstract]   [Full Text] [Related]  

  • 52. Inosine prabonex in the treatment of chronic hepatitis C.
    Laskus T; Radkowski M; Cianciara J
    J Hepatol; 1992 Nov; 16(3):388. PubMed ID: 1283173
    [No Abstract]   [Full Text] [Related]  

  • 53. [A case of severe chronic active hepatitis treated with hemoperfusion].
    Kunakov IuI; Salamov GR; Myza BN
    Ter Arkh; 1991; 63(1):122-4. PubMed ID: 2057883
    [No Abstract]   [Full Text] [Related]  

  • 54. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002148. PubMed ID: 15846629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative study of different types of treatments in chronic active hepatitis.
    Bahgat MH; Sabbour MS; Osman LM; Ghali AF; Gadallah MA
    Chemioterapia; 1985 Jun; 4(3):227-35. PubMed ID: 2411437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of chronic active hepatitis (HBsAg +,HBeAg +) with isoprinosine. Clinical evaluation].
    Cianciara J; Loch T; Babiuch L; Dabrowska-Bernstein B; Stasiak A; Dabrowski M; Pawińska A
    Pol Tyg Lek; 1988 Sep; 43(37):1195-8. PubMed ID: 2470069
    [No Abstract]   [Full Text] [Related]  

  • 57. [Evaluation of the treatment of chronic active hepatitis (HBsAg+) with isoprinosine. II. Immunological studies].
    Dabrowska-Bernstein B; Stasiak A; Dabrowski M; Pawińska A; Cianciara J; Loch T; Babiuch L
    Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):347-51. PubMed ID: 1700402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunosuppressive therapy in chronic active hepatitis (CAH). A multicentric retrospective study on 867 patients. A report from a study group for CAH of the Italian Association for the study of the liver.
    Giusti G; Piccinino F; Galanti B; Sagnelli E; Ruggiero G; Gallo C
    Hepatogastroenterology; 1984 Feb; 31(1):24-9. PubMed ID: 6698485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of autoimmune chronic active hepatitis and of primary biliary cirrhosis].
    Renner EL
    Schweiz Med Wochenschr; 1994 Mar; 124(12):495-501. PubMed ID: 8159985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Corticosteroid therapy for chronic active hepatitis.
    Am J Gastroenterol; 1984 Jul; 79(7):573-5. PubMed ID: 6377879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.